Transplant Meds – Brand vs Generic
As many of you transplantees may already know, CellCept is now available in generic, and Prograf has lost patent protection (although I’m not aware of any generic versions yet; correct me if I’m wrong).
I discussed this with my transplant surgeon at my last appointment (BEFORE I found out I had BK virus and was taken off CellCept). He said he preferred me to take brand CellCept, but that if my insurance didn’t cover it, I’d have to take generic. I pressed him as to whether there is an appreciable difference between brand and generic, and he eventually said “no”, but that he preferred I’d take the brand. (huh?)
I discussed this with a pharmacist I work with, and he explained that in some drugs, if there’s a narrow therapuetic index (the difference between therapuetic and toxic), then it may be an issue, but with CellCept, it shouldn’t be an issue. (I hope I got that right)
Anyway, I had read somewhere on an internet forum that there may be up to 15% variability between brand and generic as allowed by the FDA, but this is apparently FALSE. Given that there is only a low single digit difference between the 2, it’s not a concern, especially as there are OTHER factors with absorption, such as interference from foods and minerals. In other words, your drug levels will be pretty close each time you take a med, but never exactly the same.
I plan on taking generic when I’m back on CellCept. My rationale:
- My insurance has a “lifetime limit” of drug coverage. By taking the lower priced med, I will reach that later rather than sooner
- I have periodic ICF’s (Immune Cell Function) done; this should pick up on any problems
For those who will stay on brand CellCept, here is a link to some help with co-pays (unless you are on Medicare or Medicaid): click on “Click here for details” at the CellCept for Living website.
For those on Prograf, check out the Prograf Value Card program.
Thoughts on this?



